Stock Events

Stock Events

Azora Therapeutics 

$3.81
66
-$1.00-20.79%Friday 20:00
+$0.04+1.05%Friday 20:53After hours

Statistics

Day High
4.02
Day Low
4
52W High
4.71
52W Low
3.03
Volume
8,020
Avg. Volume
-
Mkt Cap
10.01M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 18Expected
Q2 2026
Next
-11.25
-7.56
-3.87
-0.18
Expected EPS
-0.175
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AZR. It's not an investment recommendation.
Amazon
7
AMZN
Alphabet
7
GOOGL
NVIDIA
6
NVDA
Palantir Technologies
6
PLTR

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alkermes
ALKS
Mkt Cap7B
Alkermes plc focuses on central nervous system (CNS) diseases, including addiction, which competes with Adial's focus on addiction treatments.
Indivior Pharmaceuticals
INDV
Mkt Cap4.79B
Indivior PLC offers products for the treatment of opioid dependence, directly competing with Adial's addiction treatment portfolio.
Opko Health
OPK
Mkt Cap1.16B
OPKO Health, Inc. has a diverse portfolio, including pharmaceuticals for addiction, making it a competitor in the addiction treatment market.
Acadia Pharmaceuticals
ACAD
Mkt Cap3.44B
ACADIA Pharmaceuticals Inc. focuses on CNS disorders, a market that overlaps with Adial's addiction and alcohol use disorder treatments.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.07B
BioMarin Pharmaceutical Inc. develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, potentially competing in the broader pharmaceutical market.
Jazz Pharmaceuticals
JAZZ
Mkt Cap15.3B
Jazz Pharmaceuticals plc has a portfolio that includes CNS treatments, competing in the same therapeutic area as Adial.
Supernus Pharmaceuticals
SUPN
Mkt Cap2.47B
Supernus Pharmaceuticals, Inc. focuses on developing and commercializing products for the treatment of CNS diseases, overlapping with Adial's market.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap49.09B
Teva Pharmaceutical Industries Limited operates in generic and specialty medicines, including CNS and addiction treatments, making it a broad competitor.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals Incorporated is involved in creating transformative medicines for people with serious diseases, potentially competing in innovation and market share.

About

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Show More
CEO
Cary John Claiborne
Employees
6
Country
United States
ISIN
US0548001074

Listings

NASDAQ
US
ADIL
BOATS
BOATS
ADIL.BOATS
XNAS
US
AZR

0 Comments

Share your thoughts

FAQs

What is Azora Therapeutics stock price today?▼
The current price of AZR is $3.81 USD — it has decreased by -20.79% in the past 24 hours. Watch Azora Therapeutics stock price performance more closely on the chart.
What is Azora Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Azora Therapeutics stocks are traded under the ticker AZR.
What is Azora Therapeutics market cap?▼
Today Azora Therapeutics has the market capitalization of 10.01M
When is the next Azora Therapeutics earnings date?▼
Azora Therapeutics is going to release the next earnings report on November 18, 2026.
What were Azora Therapeutics earnings last quarter?▼
AZR earnings for the last quarter are -11.25 USD per share, whereas the estimation was -1.03 USD resulting in a -989.59% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Azora Therapeutics have?▼
As of November 2, 2026, the company has 6 employees.
In which sector is Azora Therapeutics located?▼
Azora Therapeutics operates in the Health & Wellness sector.
When did Azora Therapeutics complete a stock split?▼
Azora Therapeutics has not had any recent stock splits.
Where is Azora Therapeutics headquartered?▼
Azora Therapeutics is headquartered in CHARLOTTESVILLE, United States.